FeesSafety
Pluang+

Meridian and March of Dimes partner with $1.185M to boost maternal and infant health in Chicagoland.

Market News
10 Nov 2026, 20:01 WIB
PRNewsWire
View Source
Bullish
Meridian and March of Dimes partner with $1.185M to boost maternal and infant health in Chicagoland.

Meridian Health Plan of Illinois and March of Dimes have formed a $1.185 million partnership to enhance maternal and infant health services in Chicagoland. The funding supports community events and the launch of a new mobile health unit in early 2027 aimed at reducing maternal health risks and improving birth outcomes. This initiative addresses significant health disparities, with high rates of low birthweight and preterm births in Illinois and Chicago. The partnership builds on previous successful community programs and aims to increase access to care for underserved moms and babies.

Meridian Health Plan of Illinois' partnership news is presented with health sector market data for context. For readers following health stocks, here is Pluang's market snapshot as of Nov 11, 2026 00:02 WIB: out of 150 priced US health stocks, 27 rose and 122 fell. Notable movers include Dyne Therapeutics Inc. (DYN) at USD 17.63 with a -5.32% change, Bruker Corporation (BRKR) at USD 63.11 down 5.15%, and Brookdale Senior Living Inc. (BKD) at USD 8.87 down 4.73%.

More News

EssilorLuxottica reports total shares and voting rights as of October 31, 2026, with a 31% voting cap per shareholder.

EssilorLuxottica reports total shares and voting rights as of October 31, 2026, with a 31% voting cap per shareholder.

As of October 31, 2026, EssilorLuxottica disclosed its total number of shares at 464,247,548 and actual voting rights at 458,376,127 after deducting treasury shares. The company enforces a 31% voting rights cap per shareholder, as outlined in its sta...

Company Fundamentals
Neutral
1 hour ago
EssilorLuxottica reports 464 million shares and voting rights as of October 31, 2026, with a 31% voting cap.

EssilorLuxottica reports 464 million shares and voting rights as of October 31, 2026, with a 31% voting cap.

EssilorLuxottica disclosed its share capital and voting rights as of October 31, 2026, reporting 464,247,548 shares outstanding and 458,376,127 real voting rights excluding treasury shares. The company applies a 31% cap on voting rights per sharehold...

Company Fundamentals
Neutral
1 hour ago
Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...

Bullish
2 hours ago
Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...

Others
Bullish
2 hours ago
New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...

Others
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App